BIIB
Biogen Inc
NASDAQ: BIIB · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$194.38
+6.00% today
Updated 2026-04-29
Market cap
$28.53B
P/E ratio
20.92
P/S ratio
2.88x
EPS (TTM)
$9.29
Dividend yield
—
52W range
$115 – $202
Volume
1.1M
Biogen Inc (BIIB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $841.27M | $1.02B | $1.56B | $1.07B | $1.62B | $1.73B | $1.88B | $2.35B | $2.94B | $3.72B | $4.52B | $4.55B | $6.19B | $7.08B | $4.23B | $3.64B | $1.38B | $1.55B | $2.88B | $2.20B |
| Capital expenditures | $198.31M | $284.11M | $275.95M | $165.65M | $173.06M | $252.18M | $254.55M | $3.51B | $287.80M | $643.00M | $616.10M | $867.40M | $770.60M | $514.50M | $551.80M | $294.90M | $240.30M | $311.40M | $359.80M | $153.80M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $126.78M | $123.13M | $146.21M | $160.90M | $167.83M | $113.00M | $118.57M | $136.29M | $155.30M | $161.40M | $154.80M | $128.00M | $157.50M | $182.30M | $198.30M | $238.60M | $254.10M | $264.20M | $291.20M | $290.80M |
| Free cash flow | $642.96M | $736.53M | $1.29B | $909.25M | $1.45B | $1.48B | $1.63B | $-1.16B | $2.65B | $3.07B | $3.91B | $3.68B | $5.42B | $6.56B | $3.68B | $3.35B | $1.14B | $1.24B | $2.52B | $2.05B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $1.51B | $986.98M | $4.36M | $11.78M | $27.06M | $67.43B | $66.70B | $54.83B | $5.93B | $0.00 | $302.70M | $36.40M | — | $4.60M | $700000.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-44.28M | $185.08M | $-242.41M | $52.08M | $23.88M | $643.27M | $148.90M | $1.05B | $-792.10M | $-349.20M | $1.69B | $-1.65B | $990.00M | $1.21B | — | — | — |